Home > Investors > Investor FAQs
Investor FAQs
What year was ReGen incorporated and in what state?
Who are ReGen's independent accountants?
Who is ReGen's transfer agent?
How can I purchase ReGen stock?
Where is ReGen stock traded?
What is the ticker symbol?
How many shares are outstanding?
How do I conduct transactions on restricted stock, e.g. preferred stock, rule 144 exceptions, etc.?
What year was ReGen incorporated and in what state?
ReGen Biologics, Inc. was incorporated as APACHE Medical Systems, Inc. in 1987 as a Delaware corporation. After the sale of substantially all of its assets in 2001, the name of the company was changed to Aros Corporation. In 2002, in connection with the reverse merger and change of business direction, the company changed its name to ReGen Biologics, Inc.
Who are ReGen's independent accountants?
ReGen's independent accountants are Ernst & Young, LLP.
Who is ReGen's transfer agent?
All questions regarding your ownership of ReGen stock should be addressed to our transfer agent:
Computershare Trust Company, N.A.
P.O. Box 43016
Providence, RI 02940-3016 USA
Phone Numbers: (877)282-1168 (Toll-free U.S. and Canada)
or (781)575-2518 (Hearing Impaired)
Fax Number: (781)828-8813
Website: www.computershare.comHow can I purchase ReGen stock?
ReGen stock can be bought or sold through a stockbroker, bank, or generally through a financial institution that provides brokerage services.
Where is ReGen stock traded?
ReGen Biologics, Inc. common stock trades over the counter (OTC) under the symbol RGBI.
What is the ticker symbol?
The symbol for ReGen is RGBI.
How many shares are outstanding?
For the most current information on outstanding shares, please refer to the ReGen IR Presentation in the Investor Relations Kit.
How do I conduct transactions on restricted stock, e.g. preferred stock, rule 144 exceptions, etc.?
To conduct such transactions, please select the appropriate transaction, right click the link and choose, "Save Target As..." to download to your desktop. Follow the instructions and/or complete the attached form as required.
Summary: Conversion and/or Sale of Restricted Securities (3MB)
Form A: Request for Conversion of Preferred Stock (900K)
Form B: Request for Sale or Removal of Restrictive Legend (144(k)) (2.6MB)
Form C: Request for Sale of Registered Common Shares (1.5MB)
Form D: Stockholder's Representation Letter (Rule 144 Sale) (2.2MB)
Form E: Broker's Representation Letter (Rule 144 Sale) (1.4MB)
If you have any questions, contact Brion Umidi bumidi@regenbio.com.
The above downloadable documents are viewable in Acrobat format. You must have version 3.01 or higher of the Adobe Acrobat Reader to view them. To obtain this latest version, click here.
Email a friend
Print this page